@article{article, title  = {{Carfilzomib, lenalidomide, dexamethasone, and cyclophosphamide (KRdc) as induction therapy for transplant-eligible, newly diagnosed multiple myeloma patients (Myeloma XI+): Interim analysis of an open-label randomised controlled trial}},

 publisher = {{Public Library of Science (PLoS)}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Jackson GH and Pawlyn C and Cairns DA and de Tute RM and Hockaday A and Collett C and Jones JR and Kishore B and Garg M and Williams CD and Karunanithi K et al}},

 doi = {{10.1371/journal.pmed.1003454}},

 volume = {{18}},

 journal = {{PLOS Medicine}},

 issue = {{1}},

 note = {{Accessed on 2024/12/22}}}